Macquarie Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,759
Closed -$27.6K 2090
2022
Q2
$14K Hold
1,759
﹤0.01% 2397
2022
Q1
$19 Hold
1,759
﹤0.01% 2408
2021
Q4
$31K Sell
1,759
-943
-35% -$18.3K ﹤0.01% 2294
2021
Q3
$55K Sell
2,702
-1,202,333
-100% -$30.9M ﹤0.01% 2199
2021
Q2
$39.8M Buy
1,205,035
+987,439
+454% +$37.3M 0.03% 601
2021
Q1
$8.5M Buy
217,596
+83,288
+62% +$3.91M 0.01% 759
2020
Q4
$5.86M Buy
134,308
+25,986
+24% +$888K 0.01% 845
2020
Q3
$3.07M Sell
108,322
-13,223
-11% -$418K 0.01% 928
2020
Q2
$4.42M Buy
121,545
+66,673
+122% +$1.88M 0.01% 830
2020
Q1
$996K Buy
+54,872
New +$1.2M ﹤0.01% 1096

Other funds holding ONEM

Macquarie Group's ONEM Position: Q3 2022 in Review

Macquarie Group sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 1,759 shares — an estimated $27.6K sold.

Macquarie Group first reported a position in ONEM in Q1 2020 and held it in 10 quarters. The position peaked at $39.8M in Q2 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Macquarie Group reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 1,759 1Life Healthcare shares in Q3 2022, an estimated $27.6K.
  • Macquarie Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 10 quarters.
  • Macquarie Group's 1Life Healthcare position peaked at $39.8M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.